Pacemakers Market

Market Insights:

Failure to restore the normal sinus rhythm of the heart results in an abnormal or ectopic heartbeat, often referred to as cardiac arrhythmia. The arrhythmia is initiated by three discernible etiologies, such as re-entry, automaticity, and triggers. Automaticity occurs due to alterations in the ion exchange at the cellular level. Re-entry occurs when the propagating electric impulse does not fade away and re-excites the heart even after the refractory period is over. Triggered events rarely occur from abnormalities encountered in the heart muscles’ ion exchange. Pacemakers are used in patients with cardiac arrhythmias to keep their hearts beating normally.

Pacemakers used for the treatment of irregular heartbeats are segmented as implantable and external. The implantable pacemakers are further categorized as single chamber, dual chamber, and biventricular pacemakers. There is tremendous demand for dual-chamber pacemakers due to their dual ability to stimulate the right atrium and right ventricle. Biventricular pacemakers, also known as cardiac resynchronization therapy (CRT), will serve as a lucrative market in the near future.

Data forecasting and market estimation are used to conduct a country-cross-sectional analysis of the various types of pacemakers available.

Porter’s five forces model provides an overview of the competitive rivalry in the pacemaker market. A market assessment provides comprehensive information about the existing business milieu in the pacemaker market. The Key Developments section in the company profiles tracks all the recent mergers, acquisitions, and strategic partnerships between medical device manufacturers to upgrade the technical aspects related to cardiac pacemakers. The product portfolio exhibits the various pacemakers offered by major market players, which include Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron, and ZOLL Medical Corporation.

Based on product types, the global pacemakers market is categorized into:

• Implantable
• Single Chamber
• Dual Chamber
• Biventricular
• External

Pacemakers employ electrical impulses generated by an electrode to facilitate the contraction of the heart muscles. It is a very useful device that is used for regulating the heartbeat. Pacemakers constantly detect a normal heartbeat; when there is no normal heartbeat, they are responsible for stimulating the ventricles with a low-voltage impulse. The recent technological advancements in pacemakers, such as transitional tissue welding, dynamic pacemaking technology, and microprocessor-controlled devices, are contributing to market growth. Implantable pacemakers are currently dominating the market on account of the rising prevalence of cardiac arrhythmia cases (bradycardia, tachycardia, etc.). Furthermore, the pacemakers’ multiple leads enable them to restore normal heart function. External pacemakers serve as a potential market for the management of bradyarrhythmias owing to meritorious features such as ergonomic dial design and soft keys to set stimulation parameters. The key players leading the pacemaker market are Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron, ZOLL Medical Corporation.

For the purpose of this study, the global pacemakers market is categorized into the following regional and country-specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

According to the Centers for Disease Control and Prevention’s 2015 report, approximately 2.7 to 6.1 million people in the United States have atrial fibrillation. Around 2% of people below 65 years of age and 9% of people above 65 years of age have atrial fibrillation. The occurrence is more common in people of European descent and less likely to occur in African American individuals. Rising public health awareness and an increasing number of patients being diagnosed with cardiac arrhythmia drive the pacemaker market in North America.

Technological advancements in the development of pacemakers in Western Europe and the rising prevalence of cardiac complications in Eastern Europe drive the pacemaker market in Europe. Asia Pacific will be the most potential regional market during the forecast period from 2018 to 2026, owing to the growing penetration of major medical device companies manufacturing cardiac pacemakers. The affordable reimbursement scenario for cardiac pacemakers also contributes to the growth of the market in the Asia Pacific.

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Pacemakers Market Portraiture
2.1.1. Global Pacemakers Market, by Product, 2017 (US$ Mn)
2.1.2. Global Pacemakers Market, by Geography, 2017 (US$ Mn)

Chapter 3. Pacemakers Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Pacemakers Market, 2016-2026 (US$ Mn)
3.8. Competitive Landscape: Global Pacemakers Market, by Key Players, 2016-2026 (US$ Mn)

Chapter 4. Global Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Implantable
4.2.1. Single Chamber
4.2.2. Dual Chamber
4.2.3. Biventricular
4.3. External

Chapter 5. Global Pacemakers Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Pacemakers Market Analysis, 2016 – 2026
5.2.1. North America Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
5.2.2. North America Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Pacemakers Market Analysis, 2016 – 2026
5.3.1. Europe Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
5.3.2. Europe Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Pacemakers Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. India
5.4.2.4. Rest of APAC
5.5. Latin America Pacemakers Market Analysis, 2016 – 2026
5.5.1. Latin America Pacemakers Market, by Product, 2016– 2026 (US$ Mn)
5.5.2. Latin America Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Pacemakers Market Analysis, 2016 – 2026
5.6.1. MEA Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
5.6.2. MEA Pacemakers Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Boston Scientific Corporation
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Biotronik, Inc.
6.3. Cordis, Inc.
6.4. Medtronic Plc.
6.5. MEDICO S.p.A.
6.6. OSCOR, Inc.
6.7. Pacetronix
6.8. St. Jude Medical
6.9. Vitatron
6.10. ZOLL Medical Corporation

List of Figures

FIG. 1 Pacemakers: Market Segmentation
FIG. 2 Global Pacemakers Market Share, by Product, 2017 (Value %)
FIG. 3 Global Pacemakers Market Share, by Geography, 2017 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2017
FIG. 6 Single Chamber Implantable Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 7 Dual Chamber Implantable Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 8 Biventricular Implantable Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 9 External Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 10 U.S. Pacemakers Market, 2016– 2026 (US$ Mn)
FIG. 11 Canada Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 12 U.K. Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 13 Germany Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 14 Rest of Europe Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 15 Japan Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 16 China Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 17 India Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Asia Pacific Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 19 Brazil Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 20 Mexico Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Latin America Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 22 GCC Pacemakers Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Middle East and Africa Pacemakers Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Pacemakers Market Portraiture
TABLE 2 Global Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Implantable Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 4 Global Pacemakers Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Pacemakers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa Pacemakers Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa Pacemakers Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 15 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Biotronik, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Cordis, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Pacetronix: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 St. Jude Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Vitatron: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 ZOLL Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)